Toggle Main Menu Toggle Search

Open Access padlockePrints

Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 months

Lookup NU author(s): Julie Coaker, Professor Sir John BurnORCiD, Professor John Mathers


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


The Apc1638N mouse model, which carries a targeted mutant allele within the adenomatous polyposis (Apc) gene and develops intestinal tumours spontaneously, predominantly in the small bowel, was used to investigate the effects of two potential chemopreventive agents, aspirin and α-amylase resistant starch (RS). Heterozygous Apc+/Apc1638N mice were fed semi-purified diets rich in animal fat, animal proteins and sucrose and low in dietary fibre (Western style diets) from ~ 6 weeks up to 6 months of age. Two of the diets contained aspirin (300 mg/kg diet) and two RS (1:1 mixture of raw potato starch: Hylon VII at 200 g/kg diet) in a 2 x 2 factorial design. A fifth treatment group were fed a conventional rodent chow diet. The mice fed the Western style diets became almost three times as fat as the chow-fed mice but this did not affect tumour yield. Treatment with RS resulted in significantly more intestinal tumours whereas aspirin alone had no effect. However, there was a significant aspirin x RS interaction, which suggests that aspirin could prevent the small intestine tumour-enhancing effects of RS in this Apc-driven tumorigenesis model. The possibility that large amounts of purified forms of resistant starch may have adverse effects within the small bowel is a novel observation that requires further investigation since greater intakes of starchy foods (and of RS) are being encouraged as a public health measure in compensation for reduced dietary fat intake. However, it remains possible that any increased risk is restricted to carriers of germline mutations in APC.

Publication metadata

Author(s): Williamson SLH, Kartheuser A, Coaker J, Kooshkghazi MD, Fodde R, Burn J, Mathers JC

Publication type: Article

Publication status: Published

Journal: Carcinogenesis

Year: 1999

Volume: 20

Issue: 5

Pages: 805-810

Print publication date: 01/01/1999

ISSN (print): 0143-3334

ISSN (electronic): 1460-2180

Publisher: Oxford University Press


DOI: 10.1093/carcin/20.5.805

PubMed id: 10334197


Altmetrics provided by Altmetric